TOKYO, March 29 (Reuters) – Japan’s Nikkei share average rose on Thursday, helped by gains in domestic-demand stocks, but Takeda Pharmaceutical stumbled after it said it was considering a bid for London-listed Shire that could top $40 billion. The Nikkei …
( read original story …)